Hostname: page-component-74656f9884-8r8nv Total loading time: 0 Render date: 2026-11-07T09:53:46.560Z Has data issue: false hasContentIssue false

Percutaneous closure of an atrial septal defect in adult patients with congenitally corrected transposition of the great arteries

Published online by Cambridge University Press:  13 February 2023

Zahra Khajali
Affiliation:
Cardiology, Rajaie Cardiovascular Medical and Research Center, Iran
Amin Sayyadi
Affiliation:
Student Research Committee, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran
Atta Firouzi
Affiliation:
Cardiology, Rajaie Cardiovascular Medical and Research Center, Iran
Maryam Aliramezany*
Affiliation:
Cardiovascular Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran
*
Author for correspondence: Maryam Aliramezany, Cardiovascular Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran. Tel: 989131961016; Fax: 986632228901. E-mail: maliramezany@yahoo.com
Rights & Permissions [Opens in a new window]

Abstract

Congenitally corrected transposition of great arteries is a rare anomaly which are responsible for 0.5% of all CHDs and can be associated with other congenital cardiac abnormalities. Association of congenitally corrected transposition of great arteries and isolated atrial septal defect is a very rare condition, and management of this association is challenging. In this paper, we describe three patients with congenitally corrected transposition of great arteries and isolated atrial septal defect who were admitted to our clinic and all of them underwent percutaneous closure of defect. From 2017 to 2020, we visited three patients with congenitally corrected transposition of great arteries and isolated atrial septal defect. Our patients’ ages ranged from 28 to 38 years. All of them underwent percutaneous atrial septal defect device closure without any complications. Patients were discharged from hospital in good condition with a daily dose of Aspirin 80 mg and Plavix 75 mg. For all of them, follow-up echocardiography was performed the day after the procedure at 1, 3, and 6 months later and showed the function of the right-sided left ventricle improvement and the severity of the mitral regurgitation was reduced. Furthermore, clinical evaluation also indicated functional class improvement. Although the cases of percutaneous transcatheter closure are few and cannot be regarded as strong evidence to recommend this procedure, the outcomes are promising and can demonstrate that this approach is practical.

Information

Type
Brief Report
Copyright
© The Author(s), 2023. Published by Cambridge University Press
Figure 0

Figure 1. Ventricular discordance in four-chamber view.

Figure 1

Figure 2. Ventricular discordance associated with large secundum-type atrial septal defect (star) in cardiac MRI.

Figure 2

Figure 3. Atrial septal defect device was seen in proper position in angiographic view.

Figure 3

Table 1. Demographic and paraclinical data of the patients.

Figure 4

Table 2. Previous studies on CC-TGA patients with percutaneous ASD closure.